The Vanguard Group 13D and 13G filings for Beam Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:00 pm Purchase |
2023-12-29 | 13G | Beam Therapeutics Inc. BEAM |
The Vanguard Group | 7,164,843 8.790% |
891,213 (+14.21%) |
Filing |
| 2023-02-09 11:07 am Purchase |
2022-12-30 | 13G | Beam Therapeutics Inc. BEAM |
The Vanguard Group | 6,273,630 8.900% |
1,576,365 (+33.56%) |
Filing |
| 2022-02-09 3:24 pm Purchase |
2021-12-31 | 13G | Beam Therapeutics Inc. BEAM |
The Vanguard Group | 4,697,265 6.890% |
4,697,265 (New Position) |
Filing |